Table 1.
Resistance rate of P. aeruginosa to antibiotics in 2017–2021 (%).
| Characteristics | 2017 | 2018 | 2019 | 2020 | 2021 | Total | p |
|---|---|---|---|---|---|---|---|
| Imipenem | 25.9 (151/583) |
19.1 (114/596) |
21.4 (133/621) |
23.1 (127/548) |
22.7 (155/682) |
22.4 (680/3030) |
0.980 |
| Meropenem | 22.5 (80/355) |
15.8 (92/582) |
18.5 (112/607) |
20.0 (109/544) |
20.8 (140/673) |
19.3 (533/2761) |
0.402 |
| Aztreonam | 17.0 (35/206) |
19.3 (107/555) |
26.7 (98/367) |
22.5 (92/408) |
21.2 (112/529) |
21.5 (444/2065) |
0.210 |
| Ciprofloxacin | 14.7 (83/565) |
13.5 (80/594) |
15.2 (94/620) |
11.3 (62/548) |
12.2 (83/681) |
13.4 (402/3008) |
0.120 |
| Levofloxacin | 11.4 (66/578) |
12.2 (73/596) |
12.6 (78/621) |
10.2 (56/547) |
11.4 (78/682) |
11.6 (351/3024) |
0.624 |
| Ceftazidime | 10.4 (61/587) |
11.3 (67/594) |
5.4 (32/590) |
11.3 (62/547) |
12.0 (82/682) |
10.1 (304/3000) |
0.351 |
| Piperacillin | 11.6 (41/352) |
10.2 (57/560) |
10.3 (62/600) |
10.8 (58/538) |
11.2 (74/658) |
10.8 (292/2708) |
0.985 |
| Cefepime | 9.4 (55/585) |
8.9 (53/594) |
7.4 (46/618) |
7.3 (40/548) |
4.8 (31/648) |
7.5 (225/2993) |
0.001 |
| Piperacillin/Tazobactam | 7.7 (45/582) |
7.8 (46/592) |
6.6 (41/617) |
5.8 (32/548) |
8.0 (54/676) |
7.2 (218/3015) |
0.668 |
| Gentamicin | 3.8 (22/579) |
4.9 (29/587) |
5.2 (32/620) |
3.7 (20/547) |
4.4 (30/680) |
4.4 (133/3013) |
0.974 |
| Tobramycin | 3.4 (20/586/) |
4.0 (24/596) |
5.5 (34/620) |
3.6 (20/548) |
4.6 (31/681) |
4.3 (129/3031) |
0.534 |
| Amikacin | 1.9 (11/585) |
1.7 (10/597) |
1.5 (9/619) |
1.5 (8/546) |
2.2 (15/680) |
1.8 (53/3027) |
0.730 |